Valuation: QuidelOrtho Corporation

Market Cap 808M 696M 659M 597M 1.12B 77.18B 1.13B 7.83B 3.01B 39.26B 3.03B 2.97B 124B P/E 2026 *
-2.86x
P/E 2027 * -4.25x
Enterprise Value 3.52B 3.03B 2.87B 2.6B 4.88B 336B 4.91B 34.11B 13.12B 171B 13.22B 12.93B 541B EV / Sales 2026 *
1.38x
EV / Sales 2027 * 1.32x
Free-Float
99.11%
Yield 2026 *
-
Yield 2027 * -
1 day-2.33%
1 week-13.86%
Current month-20.13%
1 month-19.41%
3 months-20.90%
6 months-34.70%
Current year-59.65%
1 week 11.4
Extreme 11.4
14
1 month 11.4
Extreme 11.4
15.5
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
76.9
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 06/05/2024
Director of Finance/CFO 48 06/07/2026
Chief Operating Officer 57 15/11/2024
Director TitleAgeSince
Chairman 72 11/12/2022
Director/Board Member 71 01/01/2022
Director/Board Member 82 01/01/1993
Date Insider Type Main position Quantity % Market Cap. Importance
15/08/26 Exercice

EVP Global Port. Mgmt & Mkting

1,054 0.0015% -
15/07/26 Free

Chief Financial Officer

356,555 0.5251%
06/07/26 Other

Chief Financial Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-2.33%-13.86%-60.15%-84.91% 808M
-2.15%-2.48%+15.13%-33.42% 16.73B
+1.03%+6.31%-34.38%+45.06% 1.75B
+0.41%-1.83%-28.49%+22.12% 893M
+0.14%-0.03%+61.02%-2.51% 778M
+0.19%-4.99%-38.74%-49.84% 637M
+1.76%-8.00%-42.32%-51.29% 560M
-0.90%-12.45%-43.86%-39.58% 450M
-0.25%-0.62%-8.52%-4.73% 397M
+2.10%-1.22%+60.96%+46.82% 393M
Average +0.19%-5.44%-11.93%-15.23% 2.34B
Weighted average by Cap. -1.31%-2.64%+5.08%-25.33%

Financials

2026 *2027 *
Net sales 2.54B 2.19B 2.08B 1.88B 3.53B 243B 3.55B 24.65B 9.48B 124B 9.56B 9.35B 391B 2.59B 2.23B 2.11B 1.92B 3.6B 248B 3.61B 25.11B 9.66B 126B 9.73B 9.52B 398B
Net income -282M -243M -230M -208M -391M -26.9B -393M -2.73B -1.05B -13.68B -1.06B -1.03B -43.24B -190M -164M -155M -141M -264M -18.18B -265M -1.84B -709M -9.25B -715M -699M -29.23B
Net Debt 2.71B 2.34B 2.21B 2.01B 3.76B 259B 3.78B 26.28B 10.11B 132B 10.19B 9.96B 417B 2.62B 2.26B 2.14B 1.94B 3.64B 251B 3.66B 25.43B 9.78B 128B 9.86B 9.64B 403B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
14/09/26 $11.51 -2.33% 779,402
11/09/26 $11.78 -3.05% 1,067,986
10/09/26 $12.15 -3.88% 1,175,723
09/09/26 $12.64 -5.53% 867,150
08/09/26 $13.38 -4.22% 961,619
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
11.78USD
Average target price
14.67USD
Spread / Average Target
+24.50%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!